Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World-Reference-Cited by-同舟云学术

Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World

Published:2021-08-19 Issue:6 Volume:186 Page:739-754
ISSN:0301-486X
Container-title:Mycopathologia
language:en
Short-container-title:Mycopathologia

Author:

Muthu Valliappan,Rudramurthy Shivaprakash M.,Chakrabarti Arunaloke,Agarwal Ritesh^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Veterinary (miscalleneous),Agronomy and Crop Science,Applied Microbiology and Biotechnology,Microbiology

Link

https://link.springer.com/content/pdf/10.1007/s11046-021-00584-8.pdf

Reference125 articles.

1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (Covid-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–42. https://doi.org/10.1001/Jama.2020.2648.

2. Garg D, Muthu V, Sehgal I, Ramachandran R, Kaur H, Bhalla A, et al. Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia. 2021;186(2):289–98. https://doi.org/10.1007/S11046-021-00528-2.

3. Patel A, Agarwal R, Rudramurthy S, Shevkani M, Xess I, Sharma R, et al. Multicenter epidemiologic study of coronavirus disease-associated mucormycosis. India Emerg Infect Dis. 2021. https://doi.org/10.3201/Eid2709.210934.

4. Sharma R, Gujarat: with scarcity, fungus experts suggest alternative drugs. www://Timesofindia.Indiatimes.Com/Articleshow/82813984.Cms?Utm_Source=Contentofinterest&Utm_Medium=Text&Utm_Campaign=Cppst. Times Of India (2021)

5. Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen S, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium. Lancet Infect Dis. 2019. https://doi.org/10.1016/S1473-3099(19)30312-3.

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and prognostic factors of mucormycosis in France (2012–2022): a cross-sectional study nested in a prospective surveillance programme;The Lancet Regional Health - Europe;2024-10

2. Post COVID-19 mucormycosis in critical care settings: A prospective cohort study in a tertiary care center in Egypt;Journal of Infection and Public Health;2024-10

3. A Cluster of Diutina catenulata Funguria in Patients with Coronavirus Disease 2019 (COVID-19) Hospitalized in a Tertiary Reference Hospital from Rio de Janeiro, Brazil;Current Microbiology;2024-09-03

4. Risk Factors of COVID-19 associated mucormycosis in Iranian patients: a multicenter study;BMC Infectious Diseases;2024-08-22

5. Projecting phytochemical bacoside A anti-mucorale agent: An in-silico and in-vitro assessment;Heliyon;2024-08